LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

In a remarkable medical first, a research team from Osaka University in Japan has achieved a breakthrough in the treatment of ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ...

have relapsed or refractory ALL after at least two previous lines of therapy, or have disease that relapsed or was refractory ...

Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...

Stem cell therapy represents a groundbreaking approach in the field of regenerative medicine. It leverages the body’s stem ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right ...

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & ...

While behavioural therapy has been the primary treatment strategy for autism, there are other innovative approaches that can be utilised in the future. Find out all about it here.